BioCentury
ARTICLE | Company News

Canada approves Baxter's NeisVac-C

January 14, 2002 8:00 AM UTC

Canada granted marketing approval to BAX for its NeisVac-C meningococcal group C vaccine. BAX acquired the product through its 1999 purchase of North American Vaccine, and Shire (LSE:SHP; SHPGY) has e...